, an Online Community Dedicated to Funding NIH-Caliber Drug and Medical Device Inventions, Was Unveiled at the MAGI Clinical Research Conference in San Diego

Birmingham, MI (PRWEB) October 30, 2012

Many people dont know that theres free medical treatment available at world class sites across America. For example, there are 4,967 breast cancer studies running in the U.S. and 400 of them are looking for thousands of patients right now. Anybody needing free ‘cutting edge’ breast cancer clinical trials can visit and instantly find a treatment site in their area. The Clinical Trials page on CureLauncher lists the breast cancer trials with a convenient map to show their location.

Only CureLauncher translates the complex, medical terminology into easy to understand English. It provides a simple Request Form to complete and a representative will follow-up with the next steps. A CureLauncher concierge person is also available to answer any questions. The information is free to all users and instantly helps people connect with clinical trials that can save their life.

“This MAGI Clinical Trials gathering represented medical treatment and hope for thousands of people suffering from disease and not knowing where to turn. We are proud to support their efforts to treat every person afflicted with breast cancer and other diseases, said Founder and President, Stephen Goldner, JD, RAC. is rapidly expanding its capabilities to help all people with illnesses find medical treatment, while helping NIH-caliber medical researchers generate funding for their research.

Mr. Goldners seminar at the MAGI Conference on FDA clinical regulations for drugs and medical devices was based on his 40 years of experience getting FDA and worldwide approvals to make safer and more effective healthcare products. He is the Founder of Regulatory Affairs Associates, the FDA consultants to the National Institutes of Health in Bethesda MD.

It was discussed at the conference that of the 50,000 clinical trials that took place in the U.S. in 2009, 80 percent were delayed by at least a month due to low enrollment. Mr. Goldners regulatory expertise and credibility make CureLauncher the preferred source to connect people with clinical trials. CureLauncher addresses the current need to provide easy access for people to find clinical trials, while also providing reliable referrals to the trial sites of patients that will benefit, said Vice President David Fuehrer.

This entry was posted in Map and tagged , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply